ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P29475


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name NOS1_HUMAN
Primary accession number P29475
Secondary accession numbers None
Integrated into Swiss-Prot on April 1, 1993
Sequence was last modified on October 1, 1996 (Sequence version 2)
Annotations were last modified on    November 25, 2008 (Entry version 102)
Name and origin of the protein
Protein name Nitric oxide synthase, brain
Synonyms EC 1.14.13.39
bNOS
NOS type I
Neuronal NOS
N-NOS
nNOS
Constitutive NOS
NC-NOS
Gene name
Name: NOS1
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
PubMed=7528745 [NCBI, ExPASy, EBI, Israel, Japan]
Hall A.V., Antoniou H., Wang Y., Cheung A.H., Arbus A.M., Olson S.L., Lu W.C., Kau C.-L., Marsden P.A.;
"Structural organization of the human neuronal nitric oxide synthase gene (NOS1).";
J. Biol. Chem. 269:33082-33090(1994).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
TISSUE=Cerebellum;
PubMed=7515942 [NCBI, ExPASy, EBI, Israel, Japan]
Fujisawa H., Ogura T., Kurashima Y., Yokoyama T., Yamashita J., Esumi H.;
"Expression of two types of nitric oxide synthase mRNA in human neuroblastoma cell lines.";
J. Neurochem. 63:140-145(1994).
[3]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
TISSUE=Brain;
DOI=10.1016/0014-5793(93)81210-Q; PubMed=7678401 [NCBI, ExPASy, EBI, Israel, Japan]
Nakane M., Schmidt H.H.H.W., Pollock J.S., Foerstermann U., Murad F.;
"Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle.";
FEBS Lett. 316:175-180(1993).
[4]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
TISSUE=Retina;
DOI=10.1007/BF02150230; PubMed=8879752 [NCBI, ExPASy, EBI, Israel, Japan]
Park C.-S., Gianotti C., Park R., Krishna G.;
"Neuronal isoform of nitric oxide synthase is expressed at low levels in human retina.";
Cell. Mol. Neurobiol. 16:499-515(1996).
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 3 AND 4).
TISSUE=Testis;
DOI=10.1074/jbc.272.17.11128; PubMed=9111048 [NCBI, ExPASy, EBI, Israel, Japan]
Wang Y., Goligorsky M.S., Lin M., Wilcox J.N., Marsden P.A.;
"A novel, testis-specific mRNA transcript encoding an NH2-terminal truncated nitric-oxide synthase.";
J. Biol. Chem. 272:11392-11401(1997).
[6]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-228; ALA-394; ASP-725; ASP-864 AND ARG-1064.
Rieder M.J., Livingston R.J., Daniels M.R., Chung M.-W., Miyamoto K.E., Nguyen C.P., Nguyen D.A., Poel C.L., Robertson P.D., Schackwitz W.S., Sherwood J.K., Witrak L.A., Nickerson D.A.;
"NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).";
Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases.
[7]
INVOLVEMENT IN IHPS1 SUSCEPTIBILITY.
DOI=10.1073/pnas.0305473101; PubMed=14757827 [NCBI, ExPASy, EBI, Israel, Japan]
Saur D., Vanderwinden J.-M., Seidler B., Schmid R.M., De Laet M.-H., Allescher H.-D.;
"Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis.";
Proc. Natl. Acad. Sci. U.S.A. 101:1662-1667(2004).
Comments
  • FUNCTION: Produces nitric oxide (NO) which is a messenger molecule with diverse functions throughout the body. In the brain and peripheral nervous system, NO displays many properties of a neurotransmitter.
  • CATALYTIC ACTIVITY: L-arginine + n NADPH + m O2 = citrulline + nitric oxide + n NADP+.
  • COFACTOR: Heme group.
  • COFACTOR: Binds 1 FAD.
  • COFACTOR: Binds 1 FMN.
  • COFACTOR: Metrahydrobiopterin (BH4). May stabilize the dimeric form of the enzyme.
  • ENZYME REGULATION: Stimulated by calcium/calmodulin. Inhibited by n-Nos-inhibiting protein (PIN) which may prevent the dimerization of the protein. Inhibited by NOSIP.
  • SUBUNIT: Homodimer. Interacts with DLG4; the interaction possibly being prevented by the association between NOS1 and CAPON. Forms a ternary complex with CAPON and RASD1. Forms a ternary complex with CAPON and SYN1. Interacts with ZDHHC23. Interacts with NOSIP; which may impair its synaptic location (By similarity). Interacts with HTR4 (By similarity).
  • SUBCELLULAR LOCATION: Cell membrane, sarcolemma; Peripheral membrane protein. Cell projection, dendritic spine (By similarity). Note=In skeletal muscle, it is localized beneath the sarcolemma of fast-twitch muscle fiber by associating with the dystrophin glycoprotein complex. In neurons, enriched in dendritic spines (By similarity).
  • ALTERNATIVE PRODUCTS: 4 named isoforms [FASTA] produced by alternative splicing. Isoform 3 is produced by different alternative splicing events implicating either the untranslated exons TEX1 (TN-NOS) or TEX1B (TN-NOSB) leading to a N-terminus truncated protein which possesses enzymatic activity comparable to that of isoform 1. The C-terminal truncated isoform 4 is produced by insertion of the TEX2 exon between exons 3 and 4 of isoform 1, leading to a frameshift and a premature stop codon.
    Name1
    SynonymsN-NOS-1
    Isoform IDP29475-1
    This is the isoform sequence displayed in this entry.
    Name2
    SynonymsN-NOS-2
    Isoform IDP29475-2
    Features which should be applied to build the isoform sequence: VSP_003574.
    Name3
    SynonymsTN-NOS, TN-NOSB
    Isoform IDP29475-3
    Features which should be applied to build the isoform sequence: VSP_003571.
    Name4
    SynonymsTEX2-insertion
    Isoform IDP29475-4
    Features which should be applied to build the isoform sequence: VSP_003572, VSP_003573.
  • TISSUE SPECIFICITY: Isoform 1 is ubiquitously expressed: detected in skeletal muscle and brain, also in testis, lung and kidney, and at low levels in heart, adrenal gland and retina. Not detected in the platelets. Isoform 3 is expressed only in testis. Isoform 4 is detected in testis, skeletal muscle, lung, and kidney, at low levels in the brain, but not in the heart and adrenal gland.
  • DOMAIN: The PDZ domain in the N-terminal part of the neuronal isoform participates in protein-protein interaction, and is responsible for targeting nNos to synaptic membranes in muscles (By similarity).
  • DISEASE: Genetic variations in NOS1 gene are associated with susceptibility to infantile hypertrophic pyloric stenosis type 1 (IHPS1) [MIM:179010]. IHPS has an incidence of 1-5 per 1'000 live births in whites and a marked preponderance of males to females (4:1). IHPS is the most frequent disorder requiring surgery in the first year of life. The disorder is characterized by hypertrophy and hyperplasia of the circular muscle layer of the pylorus, leading to persistent vomiting 2-12 weeks after birth. Defective pyloric relaxation and increased pyloric smooth muscle mass have been suggested to be responsible for gastric-outlet obstruction.
  • SIMILARITY: Belongs to the NOS family.
  • SIMILARITY: Contains 1 FAD-binding FR-type domain.
  • SIMILARITY: Contains 1 flavodoxin-like domain.
  • SIMILARITY: Contains 1 PDZ (DHR) domain.
  • WEB RESOURCE: Name=Wikipedia; Note=Nitric oxide synthase entry; URL="http://en.wikipedia.org/wiki/Nitric_oxide_synthase";.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
U17327; AAA62405.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17326; AAB60654.1; ALT_SEQ; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17299; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17300; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17301; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17302; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17303; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17304; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17305; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17307; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17308; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17309; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17310; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17311; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17312; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17313; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17314; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17315; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17316; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17317; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17318; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17319; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17320; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17321; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17322; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17323; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17324; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U17325; AAB60654.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
D16408; BAA03895.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L02881; AAA36376.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U31466; AAB49040.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U66362; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
AY445095; AAR07069.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR G01946; G01946.
RefSeq NP_000611.1; -.
UniGene Hs.654410
3D structure databases
HSSP P29476; 1QAV. [HSSP ENTRY / PDB]
SMR P29475; 12-126, 304-723, 968-1402.
ModBase P29475.
PTM databases
PhosphoSite P29475; -.
Enzyme and pathway databases
BioCyc MetaCyc:MON-11229; -.
Polymorphism databases
NIEHS-SNPs NOS1.
Organism-specific databases
H-InvDB HIX0036725; -.
HGNC HGNC:7872; NOS1.
GenAtlas NOS1.
HPA CAB002167; -.
MIM 163731; gene. [NCBI / EBI]
179010; phenotype. [NCBI / EBI]
PharmGKB PA134876543; -.
GeneCards P29475.
Gene expression databases
ArrayExpress P29475; -.
CleanEx HS_NOS1; -.
GermOnline ENSG00000089250; Homo sapiens.
Ontologies
GO
GO:0042995; Cellular component: cell projection (inferred from electronic annotation from UniProtKB-KW).
GO:0005856; Cellular component: cytoskeleton (inferred from sequence or structural similarity from UniProtKB).
GO:0048471; Cellular component: perinuclear region of cytoplasm (inferred from sequence or structural similarity from UniProtKB).
GO:0001917; Cellular component: photoreceptor inner segment (inferred from sequence or structural similarity from UniProtKB).
GO:0042383; Cellular component: sarcolemma (inferred from direct assay from UniProtKB).
GO:0016529; Cellular component: sarcoplasmic reticulum (inferred from direct assay from UniProtKB).
GO:0034618; Molecular function: arginine binding (traceable author statement from UniProtKB).
GO:0046870; Molecular function: cadmium ion binding (inferred from sequence or structural similarity from UniProtKB).
GO:0005516; Molecular function: calmodulin binding (inferred from electronic annotation from InterPro).
GO:0009055; Molecular function: electron carrier activity (inferred from electronic annotation from InterPro).
GO:0050660; Molecular function: FAD binding (inferred from electronic annotation from InterPro).
GO:0010181; Molecular function: FMN binding (inferred from electronic annotation from InterPro).
GO:0020037; Molecular function: heme binding (inferred from electronic annotation from InterPro).
GO:0005506; Molecular function: iron ion binding (inferred from electronic annotation from InterPro).
GO:0050661; Molecular function: NADP binding (inferred from electronic annotation from InterPro).
GO:0004517; Molecular function: nitric-oxide synthase activity (inferred from electronic annotation from InterPro).
GO:0034617; Molecular function: tetrahydrobiopterin binding (non-traceable author statement from UniProtKB).
GO:0006527; Biological process: arginine catabolic process (inferred by curator from UniProtKB).
GO:0033555; Biological process: multicellular organismal response to stress (inferred from mutant phenotype from UniProtKB).
GO:0007520; Biological process: myoblast fusion (traceable author statement from UniProtKB).
GO:0010523; Biological process: negative regulation of calcium ion transport into cytosol (traceable author statement from UniProtKB).
GO:0042136; Biological process: neurotransmitter biosynthetic process (traceable author statement from UniProtKB).
GO:0006809; Biological process: nitric oxide biosynthetic process (inferred from electronic annotation from InterPro).
GO:0055114; Biological process: oxidation reduction (inferred from electronic annotation from UniProtKB-KW).
GO:0045909; Biological process: positive regulation of vasodilation (inferred from direct assay from UniProtKB).
GO:0055117; Biological process: regulation of cardiac muscle contraction (traceable author statement from UniProtKB).
GO:0009408; Biological process: response to heat (inferred from direct assay from UniProtKB).
GO:0001666; Biological process: response to hypoxia (inferred from expression pattern from UniProtKB).
QuickGo view.
Family and domain databases
InterPro IPR003097; FAD-binding_1.
IPR001094; Flavdoxin_like.
IPR008254; Flavodoxin/NO_synth.
IPR001709; FPN_cyt_redctse.
IPR004030; NO_synthase_oxygenase_reg.
IPR012144; NOS.
IPR001433; OxRdtase_FAD/NAD_bd.
IPR001478; PDZ.
Graphical view of domain structure.
Gene3D G3DSA:3.90.340.10; NO_synthase_oxygenase_reg; 1.
Pfam PF00667; FAD_binding_1; 1.
PF00258; Flavodoxin_1; 1.
PF00175; NAD_binding_1; 1.
PF02898; NO_synthase; 1.
PF00595; PDZ; 1.
Pfam graphical view of domain structure.
PIRSF PIRSF000333; NOS; 1.
PRINTS PR00369; FLAVODOXIN.
PR00371; FPNCR.
SMART SM00228; PDZ; 1.
SMART graphical view of domain structure.
PROSITE PS51384; FAD_FR; 1.
PS50902; FLAVODOXIN_LIKE; 1.
PS60001; NOS; 1.
PS50106; PDZ; 1.
PROSITE graphical view of domain structure (profiles).
BLOCKS P29475.
ProtoNet P29475.
Genome annotation databases
Ensembl ENSG00000089250; Homo sapiens. [Contig view]
GeneID 4842; -.
KEGG hsa:4842; -.
Phylogenomic databases
HOGENOM P29475; -.
HOVERGEN P29475; -.
Other
DrugBank DB00155; L-Citrulline.
NextBio 18658; -.
SOURCE NOS1; Homo sapiens.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
Alternative splicing; Calmodulin-binding; Cell membrane; Cell projection; FAD; FMN; Heme; Iron; Membrane; Metal-binding; NADP; Oxidoreductase; Polymorphism.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom    To Length Description FTId
CHAIN   1   1434  1434     Nitric oxide synthase, brain. PRO_0000170921
DOMAIN   17     99  83     PDZ. 
DOMAIN   760    940  181     Flavodoxin-like. 
DOMAIN   995   1242  248     FAD-binding FR-type. 
NP_BIND   886    917  32     FMN (By similarity). 
NP_BIND   1032   1043  12     FAD (By similarity). 
NP_BIND   1175   1185  11     FAD (By similarity). 
NP_BIND   1250   1268  19     NADP (By similarity). 
NP_BIND   1348   1363  16     NADP (By similarity). 
REGION   1    205  205     Interaction with NOSIP (By similarity). 
REGION   163    245  83     PIN (nNOS-inhibiting protein) binding. 
REGION   730    750  21     Calmodulin-binding (Potential). 
REGION   755    774  20     Tetrahydrobiopterin-binding (By similarity). 
METAL   420    420        Iron (heme axial ligand) (By similarity). 
VAR_SEQ   1    336        Missing (in isoform 3). VSP_003571
VAR_SEQ   285    407        PPTSGKQSPTKNGSPSKCPRFLKVKNWETEVVLTDTLHLK STLETGCTEYICMGSIMHPSQHARRPEDVRTKGQLFPLAK EFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLK DTELI -> MRKLRITEGFGVQRGSHNHPPPQENSPPQRMAAPPSVHAS SRSRTGRLRWFSLTPSTLRAHWKRDALSTSAWAPSCILLS MQGGLKTSAQKDSSSLSPKSLLINTIHQLKDLAPKPTW KGWKR (in isoform 4). VSP_003572
VAR_SEQ   408   1434        Missing (in isoform 4). VSP_003573
VAR_SEQ   509    613        Missing (in isoform 2). VSP_003574
VARIANT   228    228  1     P -> S (in dbSNP:rs9658279 [NCBI]). VAR_018948 
VARIANT   394    394  1     D -> A (in dbSNP:rs9658356 [NCBI]). VAR_018949 [3D]
VARIANT   725    725  1     N -> D (in dbSNP:rs9658403 [NCBI]). VAR_018950 
VARIANT   864    864  1     G -> D (in dbSNP:rs9658445 [NCBI]). VAR_018951 
VARIANT   1064   1064  1     Q -> R (in dbSNP:rs9658482 [NCBI]). VAR_018952 
CONFLICT   131    131        K -> E (in Ref. 4; AAB49040). 
CONFLICT   178    184        LAPRPPG -> WPQAPR (in Ref. 3 and 4). 
CONFLICT   492    493        QP -> HR (in Ref. 3; AAA36376). 
CONFLICT   549    549        V -> L (in Ref. 3; AAA36376). 
CONFLICT   563    563        G -> A (in Ref. 3; AAA36376). 
CONFLICT   1407   1407        Y -> I (in Ref. 3; AAA36376). 
Sequence information
Length: 1434 AA [This is the length of the unprocessed precursor] Molecular weight: 160970 Da [This is the MW of the unprocessed precursor] CRC64: 99235793B953BF37 [This is a checksum on the sequence]
        10         20         30         40         50         60 
MEDHMFGVQQ IQPNVISVRL FKRKVGGLGF LVKERVSKPP VIISDLIRGG AAEQSGLIQA 

        70         80         90        100        110        120 
GDIILAVNGR PLVDLSYDSA LEVLRGIASE THVVLILRGP EGFTTHLETT FTGDGTPKTI 

       130        140        150        160        170        180 
RVTQPLGPPT KAVDLSHQPP AGKEQPLAVD GASGPGNGPQ HAYDDGQEAG SLPHANGLAP 

       190        200        210        220        230        240 
RPPGQDPAKK ATRVSLQGRG ENNELLKEIE PVLSLLTSGS RGVKGGAPAK AEMKDMGIQV 

       250        260        270        280        290        300 
DRDLDGKSHK PLPLGVENDR VFNDLWGKGN VPVVLNNPYS EKEQPPTSGK QSPTKNGSPS 

       310        320        330        340        350        360 
KCPRFLKVKN WETEVVLTDT LHLKSTLETG CTEYICMGSI MHPSQHARRP EDVRTKGQLF 

       370        380        390        400        410        420 
PLAKEFIDQY YSSIKRFGSK AHMERLEEVN KEIDTTSTYQ LKDTELIYGA KHAWRNASRC 

       430        440        450        460        470        480 
VGRIQWSKLQ VFDARDCTTA HGMFNYICNH VKYATNKGNL RSAITIFPQR TDGKHDFRVW 

       490        500        510        520        530        540 
NSQLIRYAGY KQPDGSTLGD PANVQFTEIC IQQGWKPPRG RFDVLPLLLQ ANGNDPELFQ 

       550        560        570        580        590        600 
IPPELVLEVP IRHPKFEWFK DLGLKWYGLP AVSNMLLEIG GLEFSACPFS GWYMGTEIGV 

       610        620        630        640        650        660 
RDYCDNSRYN ILEEVAKKMN LDMRKTSSLW KDQALVEINI AVLYSFQSDK VTIVDHHSAT 

       670        680        690        700        710        720 
ESFIKHMENE YRCRGGCPAD WVWIVPPMSG SITPVFHQEM LNYRLTPSFE YQPDPWNTHV 

       730        740        750        760        770        780 
WKGTNGTPTK RRAIGFKKLA EAVKFSAKLM GQAMAKRVKA TILYATETGK SQAYAKTLCE 

       790        800        810        820        830        840 
IFKHAFDAKV MSMEEYDIVH LEHETLVLVV TSTFGNGDPP ENGEKFGCAL MEMRHPNSVQ 

       850        860        870        880        890        900 
EERKSYKVRF NSVSSYSDSQ KSSGDGPDLR DNFESAGPLA NVRFSVFGLG SRAYPHFCAF 

       910        920        930        940        950        960 
GHAVDTLLEE LGGERILKMR EGDELCGQEE AFRTWAKKVF KAACDVFCVG DDVNIEKANN 

       970        980        990       1000       1010       1020 
SLISNDRSWK RNKFRLTFVA EAPELTQGLS NVHKKRVSAA RLLSRQNLQS PKSSRSTIFV 

      1030       1040       1050       1060       1070       1080 
RLHTNGSQEL QYQPGDHLGV FPGNHEDLVN ALIERLEDAP PVNQMVKVEL LEERNTALGV 

      1090       1100       1110       1120       1130       1140 
ISNWTDELRL PPCTIFQAFK YYLDITTPPT PLQLQQFASL ATSEKEKQRL LVLSKGLQEY 

      1150       1160       1170       1180       1190       1200 
EEWKWGKNPT IVEVLEEFPS IQMPATLLLT QLSLLQPRYY SISSSPDMYP DEVHLTVAIV 

      1210       1220       1230       1240       1250       1260 
SYRTRDGEGP IHHGVCSSWL NRIQADELVP CFVRGAPSFH LPRNPQVPCI LVGPGTGIAP 

      1270       1280       1290       1300       1310       1320 
FRSFWQQRQF DIQHKGMNPC PMVLVFGCRQ SKIDHIYREE TLQAKNKGVF RELYTAYSRE 

      1330       1340       1350       1360       1370       1380 
PDKPKKYVQD ILQEQLAESV YRALKEQGGH IYVCGDVTMA ADVLKAIQRI MTQQGKLSAE 

      1390       1400       1410       1420       1430 
DAGVFISRMR DDNRYHEDIF GVTLRTYEVT NRLRSESIAF IEESKKDTDE VFSS 

P29475 in FASTA format

View entry in original UniProtKB/Swiss-Prot format
View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by au flag APAF Australia Mirror sites: Brazil  Canada  China  Korea  Switzerland
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!